Follow
Vivek Pradhan
Title
Cited by
Cited by
Year
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
S Vermeire, WJ Sandborn, S Danese, X Hébuterne, BA Salzberg, ...
The Lancet 390 (10090), 135-144, 2017
1892017
Choice of test for association in small sample unordered r × c tables
S Lydersen, V Pradhan, P Senchaudhuri, P Laake
Statistics in medicine 26 (23), 4328-4343, 2007
612007
A comparative study of the bias corrected estimates in logistic regression
T Maiti, V Pradhan
Statistical Methods in Medical Research 17 (6), 621-634, 2008
382008
Small-sample comparisons of confidence intervals for the difference of two independent binomial proportions
TJ Santner, V Pradhan, P Senchaudhuri, CR Mehta, A Tamhane
Computational Statistics & Data Analysis 51 (12), 5791-5799, 2007
382007
Safety, pharmacokinetic, and pharmacodynamic evaluation after single and multiple ascending doses of a novel selective androgen receptor modulator in healthy subjects
I Bhattacharya, S Tarabar, Y Liang, V Pradhan, J Owens, B Oemar
Clinical therapeutics 38 (6), 1401-1416, 2016
292016
Effect of PF-00547659 on central nervous system immune surveillance and circulating β7+ T cells in Crohn’s disease: report of the TOSCA study
G D’Haens, S Vermeire, H Vogelsang, M Allez, P Desreumaux, ...
Journal of Crohn's and Colitis 12 (2), 188-196, 2018
282018
Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b …
C Tehlirian, RSP Singh, V Pradhan, ES Roberts, S Tarabar, E Peeva, ...
Journal of the American Academy of Dermatology 87 (2), 333-342, 2022
272022
Efficacy and safety of topical brepocitinib for the treatment of mild‐to‐moderate atopic dermatitis: a phase IIb, randomized, double‐blind, vehicle‐controlled, dose‐ranging and …
MN Landis, M Arya, S Smith, Z Draelos, L Usdan, S Tarabar, V Pradhan, ...
British Journal of Dermatology 187 (6), 878-887, 2022
252022
TURANDOT: a randomized, multicenter double-blind, placebo-controlled study of the safety and efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in patients with moderate to …
S Vermeire, W Sandborn, S Danese, X Hebuterne, B Salzberg, ...
Journal Of Crohns & Colitis 9, S13-S14, 2015
252015
Bias reduction in logistic regression with missing responses when the missing data mechanism is nonignorable
AK Maity, V Pradhan, U Das
The American Statistician, 2018
232018
A randomized, multicenter double-blind, placebo-controlled study of the safety and efficacy of anti-MAdCAM antibody PF-00547659 (PF) in patients with moderate to severe …
W Reinisch, W Sandborn, S Danese, F Cataldi, X Hebuterne, B Salzberg, ...
Gastroenterology 148 (4), S1193-S1193, 2015
222015
Safety, tolerability, efficacy, pharmacokinetics, and pharmacodynamics of the oral TYK2 inhibitor PF-06826647 in participants with plaque psoriasis: a phase 1, randomised …
C Tehlirian, E Peeva, E Kieras, M Scaramozza, ES Roberts, RSP Singh, ...
The Lancet Rheumatology 3 (3), e204-e213, 2021
212021
Bias reduction and a solution for separation of logistic regression with missing covariates
T Maiti, V Pradhan
Biometrics 65 (4), 1262-1269, 2009
212009
Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study
RSP Singh, V Pradhan, ES Roberts, M Scaramozza, E Kieras, JD Gale, ...
Clinical and Translational Science 14 (2), 671-682, 2021
192021
Molecular profiling of ulcerative colitis subjects from the TURANDOT trial reveals novel pharmacodynamic/efficacy biomarkers
H Zhou, L Xi, D Ziemek, S O’Neil, J Lee, Z Stewart, Y Zhan, S Zhao, ...
Journal of Crohn's and Colitis 13 (6), 702-713, 2019
192019
Bias correction in logistic regression with missing categorical covariates
U Das, T Maiti, V Pradhan
Journal of statistical planning and inference 140 (9), 2478-2485, 2010
132010
Confidence interval of the difference of two independent binomial proportions using weighted profile likelihood
V Pradhan, T Banerjee
Communications in Statistics—Simulation and Computation® 37 (4), 645-659, 2008
132008
Binomial confidence intervals for testing non-inferiority or superiority: a practitioner’s dilemma
V Pradhan, JC Evans, T Banerjee
Statistical Methods in Medical Research 25 (4), 1707-1717, 2016
112016
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study
MN Landis, SR Smith, G Berstein, G Fetterly, P Ghosh, G Feng, V Pradhan, ...
British Journal of Dermatology 189 (1), 33-41, 2023
92023
OP007 Anti-MAdCAM monoclonal antibody PF-00547659 does not affect immune surveillance in the central nervous system of anti-TNF and immunosuppressant experienced Crohn's …
G D'Haens, S Vermeire, F Cataldi, H Vogelsang, M Allez, P Desreumaux, ...
Journal of Crohn's and Colitis 8 (Supplement_1), S4-S5, 2014
92014
The system can't perform the operation now. Try again later.
Articles 1–20